Tradewind BioScience
New accelerator entry · 2017-11-02 · the record
In their words
Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Tradewind BioScience
- Source Check — verify what Tradewind BioScience states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Tradewind BioScience for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Tradewind BioScienceYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Tradewind BioScience: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.